Nine civil society groups write WHO Executive Board about conflict of interest on WHO R&D Financing group

On January 20, 2011, 9 civil society organizations sent a letter to the WHO Executive Board registering an objection to the selection of Dr. Paul Herrling of Novartis to the WHO Consultative Expert Working Group on Research and Development: Financing and Coordination. The groups signing the letter were:

  • CIDEPRO
  • Déclaration de Berne – Berne Declaration
  • HAI Europe
  • HAI Global
  • Health GAP (Global Access Project)
  • Continue Reading

Uncategorized

European members of WHO Executive Board take hard line on nomination of Novartis official to R&D group

At the 128th meeting of the WHO Executive Board (EB), the European members of the board are reportedly taking a hard line on the proposal by Switzerland to have Paul Herrling, an executive of Novartis, appointed to the WHO Consultative Expert Working Group (CEWG) on R&D financing. Our earlier blogs on this controversy are available here and here).

Continue Reading

Uncategorized

Life Technologies funds seven $1 million medical innovation prizes

On December 14, 2010, Life Technologies Corporation, which among other things owns Ion Torrent, which sells the Ion Personal Genome Machine sequencer, announced seven new medical innovation prizes. The first three prizes are related to improvements in the Ion semiconcudtor sequencing products. Each of the three sequencer prizes is funded at $1 million, and will be awarded to contestants that can achieve the following goals:

  1. produce twice as much sequence data,
  2. Continue Reading

Uncategorized